A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy

PHASE3CompletedINTERVENTIONAL

Enrollment

320

Participants

Timeline

Start Date

September 14, 1999

Primary Completion Date

November 8, 2000

Study Completion Date

February 27, 2002

Conditions

Anemia

Interventions

DRUG

Darbepoetin alfa

Administered by subcutaneous injection once a week

DRUG

Placebo

Placebo matching to darbopoetin alfa administered by subcutaneous injection once a week.